The chemokine receptor CXCR4 promoted hypoxia-induced pulmonary hypertension and vascular remodeling in rats, and inhibition of CXCR4 significantly attenuated these effects (Yu and Hales, 2011). The gene discussed is CXCR4; the disease is pulmonary hypertension.